Comprehensive Psychiatry
Volume 45, Issue 1 , Pages 57-61 , January 2004

The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia

  • Sibel Örsel

      Affiliations

    • Department of Psychiatry, SSK Ankara Residency Training Hospital, Ankara, Turkey
    • Corresponding Author InformationAddress reprint requests to Dr. Sibel Örsel, SSK Ankara Residency Training Hospital, Tip Fak Cad, Baglar S. 17/4 Dikimevi, Ankara 06620, Turkey
    • ,
  • Asena Akdemir

      Affiliations

    • Department of Psychiatry, SSK Ankara Residency Training Hospital, Ankara, Turkey
    • ,
  • İhsan Dağ

      Affiliations

    • Department of Psychology, Hacettepe University, Ankara, Turkey

References 

  1. Fitzgerald PB, Williams CL, Corteling N, Filia SL, Brewer K, Adams A, et al.  Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand. 2001;103:387–392
  2. Awad GA, Voruganti LNP, Heslegrave RJ. A conceptual model of quality of life in schizophrenia (description and preliminary clinical validition). Qual Life Res. 1997;6:21–26
  3. Carpiniello B, Lai GL, Pariente CM, Carta MG, Rudas N. Symptoms, standards of living and subjective quality of life (a comparative study of schizophrenic and depressed out-patients). Acta Psychiatr Scand. 1997;96:235–241
  4. Gaite L, Vazquez-Barquero JL, Borra C, Balleteros J, Schene A, Welcher B, et al.  The Epsilon Study Group   Quality of life in patients with schizophrenia in five European countries (the Epsilon Study). Acta Psychiatr Scand. 2002;105:283–292
  5. Green CA, Fenn DS, Moussaoui D, Kadri N, Hoffman WF. Quality of life in treated and never-treated schizophrenic patients. Acta Psychiatr Scand. 2001;103:131–142
  6. Skevington S. Advancing cross-cultural research on quality of life (observations drawn from the WHOQOL development). Qual Life Res. 2002;11:135–144
  7. Revicki DA, Genduso LA, Hamilton SH, Ganoczy D, Beasley CM. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders (quality of life and clinical outcomes of a randomized clinical trial). Qual Life Res. 1999;8:417–426
  8. Browne S, Roe M, Lane A, Gervin M, Morris M, Kinsella A, et al.  Quality of life in schizophrenia (relationship to sociodemographic factors, symptomatology and tardive dyskinesia). Acta Psychiatr Scand. 1996;94:118–124
  9. Packer S, Husted J, Cohen S, Tomlinson G. Psychopathology and quality of life in schizophrenia. J Psychiatry Neurosci. 1997;22:231–234
  10. Voruganti LNP, Heslegrave RJ, Awad AG. Quality of life measurement during antipsychotic drug therapy of schizophrenia. J Psychiatry Neurosci. 1997;22:267–274
  11. Meijer CJ, Schene AH, Koeter MWJ. Quality of life in schizophrenia measured by the MOS SF-36 and the Lancashire Quality of Life profile (a comparison). Acta Psychiatr Scand. 2002;105:293–300
  12. Pukrop R, Möller HJ, Steinmeyer EM. Quality of life in psychiatry (a systematic contribution to construct validation and the development of the integrative assessment tool “modular system for quality of life.”). Eur Arch Psychiatry Clin Neurosci. 2000;250:120–132
  13. Power M, Harper A, Bullinger M  The WHOQOL Group . The World Health Organization WHOQOL-100 (tests of the universality of quality of life in 15 different cultural groups worldwide). Health Psychol. 1999;18:495–505
  14. The WHOQOL Group . The World Health Organization Quality of Life assessment (WHOQOL) (development and general psychometric properties). Soc Sci Med. 1998;12:1569–1585
  15. Fidaner H, Elbi H, Fidaner C, Eser SY, Eser E, Göker E. Psychometric properties of WHOQOL-100 and WHOQOL-Bref. Psychiatr Psychol Psychopharmacol. 1999;7(2 Suppl):23–40
  16. Ventura J, Green FM, Shaner A, Liberman RP. Training and quality assurance with the brief pychiatric rating scale (“the drift busters.”). Int J Methods Psychiatry Res. 1993;3:221–244
  17. Andreasan NC. Methods for assessing positive and negative symptoms. Mod Probl Pharmacopsychiatry. 1990;24:73–88
  18. Guy W. Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology. Rev. Ed.. Rockville, MD: NIMH; 1976;
  19. Ritsner M, Modai I, Rivkin O, Bystrov E, Nechamkin Y, Ponizovsky A. Distress Scale for adverse symptoms (a new instrument for measuring the relationship between adverse drug symptoms and associated distress). Eur Neuropsychopharmacol. 1999;9(Suppl):S258
  20. Russo J, Roy-Byrne P, Reeder D, Alexender M, Dwyer-O’Connor E, Dagadakis C, et al.  Longitudinal assessment of quality of life in acute psychiatric inpatients (reliability and validity). J Nerv Ment Disease. 1997;185:166–175
  21. Browne S, Clarke M, Gervin M, Waddington J, Larkin C, O’Callaghan E. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry. 2000;176:173–176
  22. Heslegrave RJ, Awad AG, Voruganti LNP. The Influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. J Psychiatry Neurosci. 1997;22:235–243
  23. Lobana A, Mattoo SK, Basu D, Grupta N. Quality of life in schizophtenia in India (comparison of three approaches). Acta Psychiatr Scand. 2001;104:51–55
  24. Skantze K, Malm U, Dencker S, May P, Corrigan P. Comparison of quality of life with standard of living in schizophrenic outpatients. Br J Psychiatry. 1992;161:797–801
  25. Röder-Wanner U, Oliver JPJ, Priebe S. Does quality of life differ in schizophrenic women and men? An empirical study. Int J Social Psychiatry. 1997;43:129–143
  26. Koivumaa-Honkanen HAT, Honkanen R, Antikainen R, Hintikka J, Viinamaki H. Self-reported life satisfaction and treatment factors in patients with schizophrenia, major depression and anxiety. Acta Psychiatr Scand. 1999;99:373–384
  27. Skevington SM, Wright A. Changes in the quality of life of patients receiving antidepressant medication in primary care (validation of the WHOQOL-100). Br J Psychiatry. 2001;178:261–267
  28. Skevington SM. Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL-100. Pain. 1998;76:395–406
  29. Ritsner M, Modai I, Endicott J, Rivkin O, Nechamkin Y, Barak P, et al.  Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry. 2000;61:880–889
  30. Huppert JD, Weiss KA, Lim R, Pratt S, Smith TE. Quality of life in schizophrenia (contributions of anxiety and depression). Schizophr Res. 2001;51:171–180

PII: S0010-440X(03)00168-8

doi: 10.1016/j.comppsych.2003.09.006

Comprehensive Psychiatry
Volume 45, Issue 1 , Pages 57-61 , January 2004

Article Tools